SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001140361-21-004340
Filing Date
2021-02-11
Accepted
2021-02-11 16:16:23
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G brhc10020144_sc13g.htm SC 13G 58339
  Complete submission text file 0001140361-21-004340.txt   59786
Mailing Address LAUTRUPSGADE 7, 5 COPENHAGEN O G7 DK-2100
Business Address LAUTRUPSGADE 7, 5 COPENHAGEN O G7 DK-2100 45-2012-6000
SUNSTONE LIFE SCIENCE VENTURES FUND II K/S (Filed by) CIK: 0001591179 (see all company filings)

IRS No.: 000000000 | State of Incorp.: G7 | Fiscal Year End: 1231
Type: SC 13G

Mailing Address OLE MAALOES VEJ 3 COPENHAGEN N G7 DK-2200
Business Address OLE MAALOES VEJ 3 COPENHAGEN N G7 DK-2200 45 39 17 82 72
Orphazyme A/S (Subject) CIK: 0001764791 (see all company filings)

IRS No.: 000000000 | State of Incorp.: G7 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-92107 | Film No.: 21619880
SIC: 2834 Pharmaceutical Preparations